Q1 2021 ConvaTec Group PLC Trading Statement Call Transcript
Ladies and gentlemen, hello, and welcome to the ConvaTec Group Plc Q1 trading update for the 3 months ended 31st of March 2021. My name is Maxine, and I'll be coordinating the call today. (Operator Instructions)
I will now hand over to your host, Frank Schulkes, CFO, to begin. Frank, please go ahead when you're ready.
Thank you very much, Maxine. Good morning, everyone, and thanks for joining us today. It's a busy morning of reporting. So I will make a few opening remarks, and then we can open it up for questions.
As well as delivering a strong performance during the first quarter, we continued to make good progress with our strategy as we pivot to sustainable and profitable growth, most notably with the acquisition of Cure Medical. The business, which is based in California, develops, manufactures and distributes intermittent catheters. And consistent with the focus and innovate pillars of our strategy, we are investing in the United States as well as enhancing our portfolio in one
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |